Replimune Group (REPL) Q4 2025 Earnings
REPL·Reported February 3, 2026·Before market open
Diluted EPS came in at $-0.77 (+2.5% YoY), missed the $-0.77 consensus by $0.00.
Diluted EPS
$-0.77missed by $0.00
Consensus: $-0.77
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about Replimune Group's Q4 2025 earnings report.
Replimune Group (REPL) reported Q4 2025 earnings on February 3, 2026 before market open.
Replimune Group reported diluted EPS of $-0.77 for Q4 2025.
EPS missed the consensus estimate of $-0.77 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 2.5% from $-0.79.
You can read the 8-K earnings release (0001104659-26-009510) and the 10-Q periodic report (0001628280-26-004805) directly on SEC EDGAR. The filing index links above go to sec.gov.